Antibody-Proteolysis Targeting Chimera Conjugate Enables Selective Degradation of Receptor-Interacting Serine/Threonine-Protein Kinase 2 in HER2+ Cell Lines (2023)
Attributed to:
Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.bioconjchem.3c00366
PubMed Identifier: 37917829
Publication URI: http://europepmc.org/abstract/MED/37917829
Type: Journal Article/Review
Parent Publication: Bioconjugate Chemistry
Issue: 11